Envestnet Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $22.1M | Buy |
91,554
+2,243
| +3% | +$491K | 0.01% | 1382 |
|
|
2026
Q1 | $16.9M | Buy |
89,311
+1,205
| +1% | +$211K | ﹤0.01% | 1467 |
|
|
2025
Q4 | $15M | Sell |
88,106
-14,075
| -14% | -$2.16M | ﹤0.01% | 1407 |
|
|
2025
Q3 | $13.5M | Sell |
102,181
-10,744
| -10% | -$1.29M | ﹤0.01% | 1569 |
|
|
2025
Q2 | $12M | Sell |
112,925
-1,713
| -1% | -$186K | ﹤0.01% | 1617 |
|
|
2025
Q1 | $14.2M | Buy |
114,638
+23,896
| +26% | +$3.12M | ﹤0.01% | 1416 |
|
|
2024
Q4 | $11.2M | Buy |
90,742
+24,443
| +37% | +$2.88M | ﹤0.01% | 1561 |
|
|
2024
Q3 | $7.39M | Buy |
66,299
+2,203
| +3% | +$241K | ﹤0.01% | 1851 |
|
|
2024
Q2 | $6.84M | Buy |
64,096
+619
| +1% | +$68.1K | ﹤0.01% | 1807 |
|
|
2024
Q1 | $7.64M | Buy |
63,477
+5,597
| +10% | +$686K | ﹤0.01% | 1696 |
|
|
2023
Q4 | $7.12M | Sell |
57,880
-3,583
| -6% | -$447K | ﹤0.01% | 1653 |
|
|
2023
Q3 | $7.96M | Buy |
61,463
+17,758
| +41% | +$2.37M | ﹤0.01% | 1517 |
|
|
2023
Q2 | $5.42M | Sell |
43,705
-470,949
| -92% | -$63.4M | ﹤0.01% | 1659 |
|
|
2023
Q1 | $6.36M | Buy |
514,654
+463,213
| +900% | +$68.5M | ﹤0.01% | 1524 |
|
|
2022
Q4 | $8.2M | Buy |
51,441
+1,753
| +4% | +$257K | ﹤0.01% | 1315 |
|
|
2022
Q3 | $6.62M | Buy |
49,688
+3,566
| +8% | +$542K | ﹤0.01% | 1369 |
|
|
2022
Q2 | $7.2M | Buy |
46,122
+5,146
| +13% | +$792K | ﹤0.01% | 1318 |
|
|
2022
Q1 | $6.38M | Buy |
40,976
+239
| +0.6% | +$34.7K | ﹤0.01% | 1459 |
|
|
2021
Q4 | $5.19M | Sell |
40,737
-1,438
| -3% | -$189K | ﹤0.01% | 1585 |
|
|
2021
Q3 | $5.49M | Sell |
42,175
-4,484
| -10% | -$677K | ﹤0.01% | 1484 |
|
|
2021
Q2 | $8.29M | Buy |
46,659
+742
| +2% | +$129K | ﹤0.01% | 1246 |
|
|
2021
Q1 | $7.55M | Sell |
45,917
-854
| -2% | -$141K | ﹤0.01% | 1203 |
|
|
2020
Q4 | $7.72M | Sell |
46,771
-23,737
| -34% | -$3.54M | 0.01% | 1048 |
|
|
2020
Q3 | $10.1M | Sell |
70,508
-14,051
| -17% | -$1.74M | 0.01% | 816 |
|
|
2020
Q2 | $9.33M | Buy |
84,559
+2,374
| +3% | +$263K | 0.01% | 804 |
|
|
2020
Q1 | $8.2M | Buy |
82,185
+25,052
| +44% | +$3.24M | 0.01% | 756 |
|
|
2019
Q4 | $8.53M | Buy |
57,133
+1,234
| +2% | +$168K | 0.01% | 867 |
|
|
2019
Q3 | $7.16M | Buy |
55,899
+6,889
| +14% | +$923K | 0.01% | 891 |
|
|
2019
Q2 | $6.99M | Buy |
49,010
+3,749
| +8% | +$504K | 0.01% | 883 |
|
|
2019
Q1 | $6.47M | Buy |
45,261
+6,496
| +17% | +$847K | 0.01% | 881 |
|
|
2018
Q4 | $4.8M | Buy |
+38,765
| New | +$5.75M | 0.01% | 901 |
|
|
2018
Q3 | – | Sell |
-5,171
| Closed | -$891K | – | 1937 |
|
|
2018
Q2 | $891K | Buy |
5,171
+4,423
| +591% | +$723K | ﹤0.01% | 1098 |
|
|
2018
Q1 | $112K | Sell |
748
-149
| -17% | -$21.9K | ﹤0.01% | 1871 |
|
|
2017
Q4 | $121K | Sell |
897
-107
| -11% | -$14.8K | ﹤0.01% | 2040 |
|
|
2017
Q3 | $147K | Buy |
1,004
+10
| +1% | +$1.51K | ﹤0.01% | 1944 |
|
|
2017
Q2 | $153K | Buy |
994
+13
| +1% | +$1.99K | ﹤0.01% | 1972 |
|
|
2017
Q1 | $141K | Buy |
981
+295
| +43% | +$38.4K | ﹤0.01% | 2058 |
|
|
2016
Q4 | $75K | Sell |
686
-8,901
| -93% | -$991K | ﹤0.01% | 2300 |
|
|
2016
Q3 | $1.17M | Sell |
9,587
-2,065
| -18% | -$278K | ﹤0.01% | 1181 |
|
|
2016
Q2 | $1.65M | Sell |
11,652
-711
| -6% | -$105K | 0.01% | 1107 |
|
|
2016
Q1 | $1.61M | Sell |
12,363
-3,611
| -23% | -$449K | 0.01% | 1091 |
|
|
2015
Q4 | $2.25M | Buy |
15,974
+5,083
| +47% | +$704K | 0.01% | 913 |
|
|
2015
Q3 | $1.45M | Buy |
10,891
+98
| +0.9% | +$16.9K | 0.01% | 1094 |
|
|
2015
Q2 | $1.9M | Buy |
10,793
+742
| +7% | +$133K | 0.01% | 1081 |
|
|
2015
Q1 | $1.74M | Buy |
10,051
+5,547
| +123% | +$952K | 0.01% | 1041 |
|
|
2014
Q4 | $737K | Buy |
4,504
+207
| +5% | +$34.4K | 0.01% | 604 |
|
|
2014
Q3 | $690K | Buy |
4,297
+2,207
| +106% | +$339K | 0.01% | 690 |
|
|
2014
Q2 | $307K | Buy |
2,090
+387
| +23% | +$53.7K | ﹤0.01% | 879 |
|
|
2014
Q1 | $236K | Sell |
1,703
-118
| -6% | -$17.8K | ﹤0.01% | 858 |
|
|
2013
Q4 | $230K | Sell |
1,821
-502
| -22% | -$51.9K | ﹤0.01% | 794 |
|
|
2013
Q3 | $214K | Buy |
2,323
+797
| +52% | +$64.3K | ﹤0.01% | 779 |
|
|
2013
Q2 | $105K | Buy |
+1,526
| New | +$93.3K | ﹤0.01% | 962 |
|
Other funds holding JAZZ
Envestnet Asset Management's JAZZ Position: Q2 2026 in Review
Envestnet Asset Management increased its Jazz Pharmaceuticals (JAZZ) stake by 2.5% in Q2 2026, buying an estimated $491K and bringing the position to 91,554 shares worth $22.1M. The position accounts for 0.01% of the portfolio, ranked #1382.
Envestnet Asset Management first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.
- Envestnet Asset Management held 91,554 shares of Jazz Pharmaceuticals worth $22.1M as of Q2 2026.
- Envestnet Asset Management bought 2,243 Jazz Pharmaceuticals shares in Q2 2026, an estimated $491K.
- Jazz Pharmaceuticals made up 0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #1382 holding.
- Envestnet Asset Management first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- 641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.
Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.